BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 32462937)

  • 21. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
    Cisek K; Krochmal M; Klein J; Mischak H
    Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Omics Model Applied to Cancer Genetics.
    Pettini F; Visibelli A; Cicaloni V; Iovinelli D; Spiga O
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics study for interpretation of genome-wide association study.
    Akiyama M
    J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.
    Ramos-Lopez O; Martinez JA; Milagro FI
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using omics approaches to understand pulmonary diseases.
    Kan M; Shumyatcher M; Himes BE
    Respir Res; 2017 Aug; 18(1):149. PubMed ID: 28774304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer Omics: Adding Understanding to Knowledge.
    Hondermarck H
    Proteomics; 2019 Nov; 19(21-22):e1800393. PubMed ID: 31556228
    [No Abstract]   [Full Text] [Related]  

  • 28. Prospects and challenges of multi-omics data integration in toxicology.
    Canzler S; Schor J; Busch W; Schubert K; Rolle-Kampczyk UE; Seitz H; Kamp H; von Bergen M; Buesen R; Hackermüller J
    Arch Toxicol; 2020 Feb; 94(2):371-388. PubMed ID: 32034435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches.
    Lee D; Park Y; Kim S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 34020548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 10. Role of high dimensional technology in preeclampsia (omics in preeclampsia).
    Youssef L; Testa L; Crovetto F; Crispi F
    Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102427. PubMed ID: 37995432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
    Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
    Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative methods for analyzing big data in precision medicine.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.
    Wu L; Xie X; Liang T; Ma J; Yang L; Yang J; Li L; Xi Y; Li H; Zhang J; Chen X; Ding Y; Wu Q
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of disease targets for precision medicine by integrative analysis of multi-omics data].
    Xie BB; Yang YD; Ding N; Fang XD
    Yi Chuan; 2015 Jul; 37(7):655-63. PubMed ID: 26351165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental and computational technologies to dissect the kidney at the single-cell level.
    Kuppe C; Perales-Patón J; Saez-Rodriguez J; Kramann R
    Nephrol Dial Transplant; 2022 Mar; 37(4):628-637. PubMed ID: 33332571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress of omics technology in the field of tumor resistance: From single
    Sun Z; Liu Y; Ouyang Q; Liu Z; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):620-627. PubMed ID: 34275931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Application of Bayesian Methods in Cancer Prognosis and Prediction.
    Chu J; Sun NA; Hu W; Chen X; Yi N; Shen Y
    Cancer Genomics Proteomics; 2022; 19(1):1-11. PubMed ID: 34949654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Cell Multi-Omics and Its Prospective Application in Cancer Biology.
    Peng A; Mao X; Zhong J; Fan S; Hu Y
    Proteomics; 2020 Jul; 20(13):e1900271. PubMed ID: 32223079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.